These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36335249)

  • 1. Long-term outcomes of chemoradiotherapy versus radiotherapy alone in patients with intermediate-risk nasopharyngeal carcinoma: a population-based analysis.
    Xu YC; Chen KH; Liang ZG; Zhu XD
    Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1793-1802. PubMed ID: 36335249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of chemotherapy for older patients with nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A propensity score matching analysis.
    Chen J; Ding J; Xu Y; Hong H; Lin X; Xu M; Yan L; Xu T; Fei Z; Chen C
    J Geriatr Oncol; 2023 Nov; 14(8):101648. PubMed ID: 37897887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of chemoradiotherapy in survival of stage Ⅳ nasopharyngeal carcinoma and establishment of a prognostic model.
    Luo HD; Xia FJ; Wu JH; Yi B
    Oral Oncol; 2022 Aug; 131():105927. PubMed ID: 35679694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comprehensive Analysis of Treatment Management and Survival Outcomes in Nasopharyngeal Carcinoma.
    Goshtasbi K; Lehrich BM; Birkenbeuel JL; Abiri A; Harris JP; Kuan EC
    Otolaryngol Head Neck Surg; 2021 Jul; 165(1):93-103. PubMed ID: 33231508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of chemotherapy in survival of stage II nasopharyngeal carcinoma.
    Pan XB; Li L; Qu S; Chen L; Liang SX; Zhu XD
    Oral Oncol; 2020 Feb; 101():104520. PubMed ID: 31841883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chemotherapy on survival in patients with stage T3-4N0M0 nasopharyngeal carcinoma.
    Pan XB; Qu S; Li L; Chen L; Liang SX; Zhu XD
    Clin Otolaryngol; 2021 Jul; 46(4):802-808. PubMed ID: 33580628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus neoadjuvant chemotherapy plus concurrent chemoradiotherapy for ascending or descending types of nasopharyngeal carcinoma: A retrospective study.
    Lin Q; Lu L; Wang X; Lin Y; Chen Y; Chen H; Chen S; Lin S; Zhang Y; Zheng P; Chen X
    Am J Otolaryngol; 2022; 43(1):103193. PubMed ID: 34509080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Who really needs it.
    Qu W; Wang X; Qiao Q; Wang Y
    Cancer Med; 2023 Mar; 12(6):6994-7004. PubMed ID: 36494918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and prognosis of elderly nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy.
    Lyu Y; Ni M; Zhai R; Kong F; Du C; Hu C; Ying H
    Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2549-2557. PubMed ID: 33021689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
    Wei Z; Zhang Z; Luo J; Li N; Peng X
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1857-1864. PubMed ID: 31062162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stage-specific roles of radiotherapy and chemotherapy in nodular lymphocyte predominant Hodgkin lymphoma patients: a propensity score-matched analysis of the SEER database.
    Wang S; Jia M; Han J; Zhang R; Huang K; Qiao Y; Chen P; Fu Z
    Cancer Med; 2021 Jan; 10(2):540-551. PubMed ID: 33249743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of Definitive Radiotherapy to Chemotherapy in Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer.
    Verma V; Allen PK; Simone CB; Gay HA; Lin SH
    J Natl Compr Canc Netw; 2017 Nov; 15(11):1383-1391. PubMed ID: 29118230
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined chemoradiation vs radiation therapy alone in stage-II nasopharyngeal carcinoma: A meta-analysis of the published literature.
    Wang S; Li S; Shen L
    Curr Probl Cancer; 2018; 42(3):302-318. PubMed ID: 29759802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practice patterns and outcomes of chemoradiotherapy versus radiotherapy alone for older patients with nasopharyngeal cancer.
    Verma V; Surkar SM; Moreno AC; Lin C; Simone CB
    Cancer Med; 2018 May; 7(5):1604-1611. PubMed ID: 29603669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined radiotherapy and chemotherapy versus radiotherapy alone in elderly patients with nasopharyngeal carcinoma: A SEER population-based study.
    Lu Y; Hua J; Yan F; Jiang C; Piao Y; Ye Z; Fu Z; Jiang H; Wang F; Jiang Y
    Medicine (Baltimore); 2021 Jul; 100(29):e26629. PubMed ID: 34398019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and efficacy of chemoradiotherapy for elderly patients with locoregionally advanced nasopharyngeal carcinoma: results from a matched cohort analysis.
    Liu H; Chen QY; Guo L; Tang LQ; Mo HY; Zhong ZL; Huang PY; Luo DH; Sun R; Guo X; Cao KJ; Hong MH; Mai HQ
    Radiat Oncol; 2013 Mar; 8():70. PubMed ID: 23521779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of induction chemotherapy in the treatment of stage II nasopharyngeal carcinoma in intensity modulated radiotherapy era.
    Li PJ; Mo HY; Luo DH; Hu WH; Jin T
    Oral Oncol; 2018 Oct; 85():95-100. PubMed ID: 30220326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of stage II nasopharyngeal carcinoma patients with or without concurrent chemotherapy: A propensity score matching study.
    Liu DH; Zhou XY; Pan YG; Chen S; Ye ZH; Chen GD
    Cancer Med; 2020 Feb; 9(4):1287-1297. PubMed ID: 31859464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection and validation of chemotherapy beneficiaries among elderly nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiation therapy (IMRT): a large real-world study.
    Wu YL; Yang KB; Huang Y; Shi JR; He QS; Chen L; Li WF; Huang XD; Lin L; Chen YP; Mao YP; Tang LL; Ma J
    Radiat Oncol; 2022 Aug; 17(1):138. PubMed ID: 35941674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of induction chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in Lymph-Node-Stage III nasopharyngeal carcinoma based on propensity score-matching.
    Liu ZC; Zeng KH; Gu ZB; Chen RP; Luo YJ; Tang LQ; Zhu KB; Liu Y; Sun XS; Zeng L
    Radiother Oncol; 2023 Jan; 178():109421. PubMed ID: 36410548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.